TX HB1103

Public institutions of higher education must adopt policies requiring opioid antagonists (such as naloxone) to be available at each campus residence hall, with provisions for acquisition, maintenance, storage, administration, and disposal

All resident advisors must be authorized and trained annually to administer opioid antagonists to anyone reasonably believed to be experiencing an opioid-related drug overdose in residence halls

Institutions must report each opioid antagonist administration to the prescribing physician within 10 business days, including recipient's age, status (student/employee/visitor), location, number of doses, and administrator's title

Physicians may prescribe opioid antagonists directly to institutions via standing orders without patient-specific requirements, and pharmacists may dispense without identifying information about the end user

Good faith immunity from civil, criminal, and disciplinary liability is provided to individuals who prescribe, administer, or assist with opioid antagonists, and to institutions for any acts or omissions under this law; implementation required by fall 2026